5th Apr 2024 12:32
Roquefort Therapeutics PLC - London-based biotechnology company - Says it has opted against a fundraise following "unusual share price movements". The company had engaged advisers to commence "market soundings" in relation to a potential placing, but says that "incorrect bulletin board comments regarding a speculative placing price," which in turn impacted its share price, turned it against the idea. Shares in Roquefort dropped 36% on Thursday from 6.89 pence each to 4.41 pence, having hovered around the 7p mark for the whole of March. Read More
